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Abstract
Purpose The relationship between 100% fruit juice (100%FJ) consumption and cardiovascular risk is object of debate: 
indeed, recently published investigations provided new but discrepant evidence on this important question and International 
dietary guidelines are not in agreement on recommendations about fruit juice consumption. Therefore, we performed a 
meta-analysis of the prospective studies and the randomised controlled trials (RCTs) that explored the relationship between 
100%FJ intake, cardiovascular risk profile and risk of cardiovascular events.
Methods We performed a systematic search of publications up to August 2019. Summary relative risks and exploration of 
linearity of the association were estimated for prospective studies and summary mean differences (MDs) calculated for RCTs.
Results A total of 21 prospective studies and 35 RCTs met the inclusion criteria. Dose–response analysis detected a signifi-
cant inverse association between low-moderate 100%FJ consumption and risk of stroke (up to 200 ml/day) or total CV events 
(up to 170 ml/day) compared with no consumption, with a non-linear relationship (p for non-linearity < 0.05). No significant 
association was found for coronary heart disease and diabetes risk. In RCTs, a favorable and significant effect of 100%FJ 
intake was detected on blood pressure (systolic, MD: − 3.14 mmHg; diastolic, MD: − 1.68 mmHg), arterial compliance 
(carotid-femoral pulse wave velocity, − 0.38 m/s) and endothelial function (flow-mediated dilation, 2.10%). Neutral effects 
were found on body weight, blood lipids and glucose metabolism.
Conclusions The results of these analyses indicate that 100%FJ consumption is not associated with higher CV risk. A non-
linear inverse dose–response relationship occurs between 100%FJ consumption and CV disease, in particular for risk of 
stroke, probably mediated by the decrease in blood pressure.
Trial registration PROSPERO registration number (CRD42019135577).
Keywords Fruit juice · Cardiovascular disease · Cardiovascular risk factors · Blood pressure · Meta-analysis
Introduction
The pivotal role of fresh fruits and vegetables in a healthy 
diet is universally acknowledged and increased consump-
tion of these foods is recommended by all the international 
guidelines for prevention of cardiovascular (CV) disease [1, 
2]. On the other hand, the role of processed fruits, and in 
particular of 100% fruit juice (100%FJ), is object of debate 
because of its reduced nutritional value compared to fresh 
fruit mainly due to the generally lower fibre content and to 
the higher caloric density. However, 100%FJ provides sub-
stantial amounts of micronutrients and bioactive substances, 
among which polyphenols, minerals and vitamins. These 
nutrients may reduce oxidative stress and improve inflam-
matory markers, glucose metabolism [3, 4] and endothelial 
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function [5], while inhibiting platelet aggregation [6]. For 
these reasons [7, 8], several studies were performed to ana-
lyse their possible influence on CV disorders, a major cause 
of death worldwide [9, 10]. While some epidemiological 
studies suggested that consumption of fruit drinks may 
have beneficial effects on CV risk [11–14], others provided 
contrasting evidence [15–17]. Unfortunately, most studies 
were not able to specify the exact properties of the fruit 
drinks consumed, i.e., whether 100%FJ or unspecified fruit 
drinks, and none explored the possibility of non-linear asso-
ciations. In addition to prospective observational studies, 
many intervention trials were carried out to investigate the 
potential effect of fruit juice intake (mostly 100%FJ) on CV 
risk profile and many of them have been the object of vari-
ous systematic reviews. One of these suggested a beneficial 
effect on diastolic blood pressure (BP) but, including several 
studies classified as low quality [18]. Other meta-analyses 
were limited to a single type of fruit or combined the effects 
of 100%FJ and fruit extracts [19, 20] or included of non-
randomised controlled trials [21, 22].
The aim of the present study was thus to perform a com-
prehensive systematic review and subsequent meta-analysis 
of the prospective studies and the randomised controlled tri-
als (RCTs) that explored the relationship between 100%FJ 
intake, CV risk profile and risk of CV events, aiming at 
clarifying the shape and strength of the dose–response 
relationship for these associations, if at all possible. As for 
prospective investigations the majority did not specify the 
type of fruit drink consumed by participants, we performed 
separate analyses of the few studies dealing with 100%FJ 
only but for completeness we also added an analysis includ-
ing all the other studies available.
Methods
Data sources and search strategy
This meta-analysis was planned, conducted and reported 
according to the PRISMA statement [23]. The study pro-
tocol was preregistered (CRD42019135577). A systematic 
search of the available publications was performed using 
MEDLINE/PubMed, Web of Science, and Scopus, up to 
May 2019. The search was later updated to August 2019. 
The search strategy, without restrictions, included the 
expressions “fruit juice” AND “cardiovascular” OR “cer-
ebrovascular” OR “stroke” OR “coronary heart” OR “blood 
pressure” OR “hypertension” OR “lipid” OR “cholesterol” 
OR “triglyceride” OR “HDL” OR “LDL” OR “glucose” OR 
“glycemia” OR “insulin” OR “HOMA” OR “weight” OR 
“BMI” OR “waist” OR “diabetes” OR “carotid” OR “flow 
mediated dilation” OR “pulse wave velocity” OR “arte-
rial compliance” OR “arterial elasticity”, or combinations 
thereof, either in medical subject headings or in the title/
abstract. Further information was retrieved through a manual 
search of references from recent reviews and relevant pub-
lished original studies.
Study selection and data extraction
The data selection was conducted and reported in accord-
ance with the PRISMA statement [23] by L.D., and was 
checked for accuracy by M.D. The titles and abstracts of the 
studies retrieved in the searches were screened to identify 
the studies that met the predefined inclusion criteria. The full 
texts of the potentially eligible studies were then retrieved 
and assessed for eligibility. Discrepancies over the inclu-
sion of studies and the interpretation of data were resolved 
in conference with a third reviewer (P.S.). Data were then 
extracted from the studies selected for inclusion by L.D. in 
accordance with the PRISMA statement, and was checked 
for accuracy by M.D.
Inclusion criteria
To be included in the meta-analysis a published study had to 
meet the following criteria, stratified by study design:
Prospective studies (a) Original articles, (b) studies with 
a prospective design, (c) studies involving the adult popu-
lation, (d) studies involving the assessment of 100% fruit 
juice (100%FJ) [24] or of unspecified fruit drinks intake as 
the baseline exposure, (e) studies in which the patients have 
a diagnosis of cardiovascular (CV) disease (i.e., total car-
diovascular events/mortality, coronary heart disease, stroke 
events/mortality) and/or are exposed to CV risk factors (e.g., 
hypertension, diabetes) which are determined prospectively 
as outcomes, (f) studies in which there is an indication of 
the number of participants exposed and the rate or number 
of events in the different categories of 100% FJ intake or of 
unspecified fruit drinks intake, (g) studies in which there 
is an assessment of relative risk (RR) or hazard ratio (HR) 
for specified 100% FJ or of unspecified fruit drink intake 
categories, (h) studies with a follow-up of at least 2 years 
(mean or median).
Intervention studies (a) Original articles, (b) randomized 
controlled trials (RCTs), (c) studies involving the adult 
population, (d) studies in which there is an indication of the 
difference in outcomes—among which CV risk factors (e.g., 
blood pressure, lipid profile, glucose homeostasis, body 
weight) or CV damage (e.g., arterial stiffness, intima media 
thickness, flow-mediated dilation)—between the intake of 
100% FJ [24] and of control drink in one or more patient 
cohorts; (e) studies in which there are indications of the 
number of participants included in the exposed and control 
groups; (f) studies in which the length of intervention is at 
least 7 days.
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Risk of bias
The risk of bias of the studies included in the meta-analyses 
was assessed according to established criteria [25]: the New-
castle–Ottawa Scale was used for the evaluation of prospec-
tive studies [26], and the Cochrane risk of bias tool was 
applied for the evaluation of randomized controlled trials 
(RCTs) [27].
Grading of evidence
The quality of the entire body of evidence was evaluated 
using the GRADE (grading of recommendations assessment, 
development, and evaluation) methodology [28]. Evidence 
was graded as high, moderate or low quality. Observational 
studies started as low and RCTs as high by default. They 
were downgraded or upgraded based on specified criteria. 
Criteria to downgrade included study limitations (risk of 
bias), inconsistency (substantial unexplained heterogeneity), 
indirectness (factors that limit generalizability), imprecision 
(95% CI cross a minimally important difference of 5%, and 
publication bias (significant evidence of small-study effects). 
Criteria to upgrade certainty of evidence included a large 
magnitude of effect, a dose–response gradient, and attenua-
tion by plausible confounding factors.
Statistical analysis
Meta-analysis on the prospective evaluation: the assessment of 
linear and non-linear association between 100%FJ or unspeci-
fied fruit drink consumption and outcomes was carried out. 
The possibility of non-linear relationship was explored by 
modelling 100% FJ or unspecified fruit drink consumption 
using restricted cubic splines with three knots at fixed percen-
tiles (25, 50, and 75%) of 100% FJ distribution. Departure from 
linearity was assessed by testing the null hypothesis that the 
coefficient of the second spline was equal to zero. A two-stage 
dose–response random-effects meta-analysis was performed 
[29, 30], which takes into account the correlation between the 
RR estimates across categories of 100% FJ or of unspecified 
fruit drink consumption. This analysis was carried out both to 
evaluate the effect in the single studies and to aggregate the 
results of all the studies. The median consumption for each 
specific category was assigned to each corresponding RR 
estimate. If the median consumption was not reported by the 
authors, the midpoint between the upper and lower boundary 
was used. If the lowest category was open-ended, its lower 
boundary was set to zero. If the upper boundary of the high-
est category was left unspecified, we assumed the category 
to be of the same amplitude as the preceding one. Statistical 
heterogeneity across the studies was also explored by Q-test.
Due to the small number of studies included in the pro-
spective evaluation (n < 10), sensitivity, publication bias, 
sub-group and meta-regression analysis were not performed.
Further analyses were carried out including unspecified 
fruit drink study results. Separate dose–response analysis 
for unspecified fruit drink consumption was performed for 
stroke risk, coronary heart disease and diabetes risk.
For the meta-analysis of RCTs: mean differences 
(MDs)—and standard errors (SEs)—of the defined outcomes 
were extracted from the selected publications. The pooled 
weighted MD and 95% CI were estimated using a random-
effect model. If these were not available, MD and SE were 
calculated from the comparison of the outcomes of 100% 
FJ and control drink intake [31]. The influence of a single 
cohort or of a particular study was estimated by sensitiv-
ity analysis. The Cochran Q test and the I2 statistic were 
used to evaluate statistical heterogeneity across the stud-
ies. Funnel plots were constructed and visually assessed for 
possible publication bias. Egger’s weighted regression test 
and Begg’s rank correlation test were also used to explore 
potential publication bias. In the case of significant funnel 
plot asymmetry, suggesting a number of possibly “missing” 
publications, the pooled estimate was recalculated based on 
the estimated number of “missing” studies and their effect 
sizes and SEs, a method known as “trim and fill”.
Subgroup and meta-regression analyses were used to 
identify associations between risk of cardiovascular risk fac-
tors and relevant study characteristics as possible sources of 
heterogeneity: total participants, age, gender, BMI, coun-
try, year of publication, length of intervention, underlying 
disease status, baseline value of the outcome and variables 
potentially involved, serving size, type of 100% FJ, study 
design, comparator, level of feeding control, energy intake, 
energy difference between intervention and comparator, 
domains of risk of bias, and assessment methods for arte-
rial stiffness. The additional analyses were not performed 
if there was a small number of cohorts for single outcome 
exploration (n < 10).
All statistical analyses were performed using the Stata 
Corp. software (version11.2; College Station, Texas, USA).
Results
Of a total of 16,762 publications retrieved, 21 prospective 
studies (8 reporting 100%FJ and 13 unspecified fruit drinks) 
[11–17, 32–45] (Online Resource-Supplemental-Tables 4–5) 
and 35 RCTs [46–81] (Online Resource-Supplemental 
Table 6) were identified that met the inclusion criteria 
(Online Resource-Supplemental Fig. 1, Online Resource-
Supplemental Table 7).
Prospective studies Of 21 prospective studies included 
in the meta-analysis: 10 studies reported data on CV risk 
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[11–17, 32, 34] (Online Resource-Supplemental Table 4), 
nine studies reported the risk only for diabetes [36, 38–45], 
one study only for hypertension [37], and finally one study 
both for diabetes and hypertension, separately [35] (Online 
Resource-Supplemental Table 5).
Cardiovascular risk A total of ten studies were included 
in the meta-analysis of CV risk assessment [11–17, 32, 
34]. One of the studies reported the results of three cohorts 
stratified by percentage of dietary energy from carbohy-
drates, hence we considered these cohorts separately [15]. 
Four studies reported analyses relative to the same cohorts 
(Nurses’ Health Study-NHS and Health Professionals’ Fol-
low-Up Study-HPFS), but focusing on different outcomes. 
Thus, each study was used for the included in only one anal-
ysis of the respective outcome. Only three studies specified 
the results for 100%FJ consumption [13, 14, 17]. All of them 
assessed 100%FJ consumption by a validated structured self-
administered food frequency questionnaire according to the 
country meal pattern, containing specific questions on the 
average and type of fruit drinks consumption (EPIC [13, 
14], Block [17]). In all the studies, the results were adjusted 
for the main confounders in multivariate models. All the 
studies had substantial high quality scores (Online Resource-
Supplemental Table 5).
Diabetes risk. A total of ten studies were included in the 
meta-analysis of diabetes risk evaluation [35, 36, 38–45]. 
Only five studies specified the results for 100%FJ con-
sumption [35, 38, 42, 44, 45]. Three of them [38, 42, 45] 
assessed 100%FJ consumption by a validated structured self-
administered food frequency questionnaire according to the 
country meal pattern, containing specific questions on the 
average and type of fruit drinks consumption (EPIC); while 
in the other two studies a validated structured food frequency 
questionnaire containing specific items on type and serving 
size of fruit drink intake was administered to all participants 
(Women’s Health Initiative food frequency questionnaire 
[35], reduced version of Block [44]). In all but one study 
[44], the results were adjusted for the main confounders in 
multivariate models. All but one study had substantial high 
quality scores (Online Resource-Supplemental Table 5).
Hypertension risk. Only two studies were included in the 
analysis of hypertension development, but their risk expres-
sion was not comparable [35, 37] (Online Resource-Supple-
mental Table 5). These two studies assessed 100%FJ intake 
by a validated food frequency questionnaire containing spe-
cific items on type and serving size of fruit drink intake 
administered to all participants (Women’s Health Initiative 
food frequency questionnaire [35], Cardia dietary history 
[37]). One study included young participants with stringent 
criteria for diagnosis of hypertension [37]. The other one 
included post-menopausal women with common criteria for 
hypertension diagnosis [35].
Quality of body of evidence According to the GRADE 
criteria the evidence for the association between 100%FJ 
consumption and CV risk was of moderate quality both for 
risk of CV events and diabetes risk. Despite the GRADE 
methodology defines observational evidence from cohort 
studies as low quality, there was an upgrade of the score 
due to dose–response gradient.
Risk of total cardiovascular disease
The analysis of the two studies that investigated the con-
sumption of 100%FJ and total CV events [13, 14] (over-
all, 65,018 participants and 4087 events, Online Resource-
Supplemental Table 4) showed a non-linear association (p 
for non-linearity = 0.02) (Fig. 1a). 100%FJ consumption up 
to 170 ml per day was associated with significantly lower 
risk of total CV events, with lowest risk at 78 ml per day 
(RR = 0.90, 95% CI 0.83–0.97) compared with no 100%FJ 
consumption (Fig. 1a). There was no significant heteroge-
neity (p = 0.97). On the other hand, a not significant effect 
of higher levels of reported 100%FJ intake over 170 ml per 
day was apparent compared with no 100% FJ consumption.
In addition, two studies that did not specify the type of 
fruit drink consumed analysed the risk of total CV events 
[15, 33]: in both cases, no significant association was 
detected between fruit drinks intake and risk of total CV 
events.
Risk of stroke
Two studies were available for the analysis of 100%FJ intake 
and risk of stroke [13, 14] (overall, 65,018 participants and 
1283 events, Online Resource-Supplemental Table 4). The 
analysis of departure from linearity for these two studies 
indicated a non-linear association between 100%FJ con-
sumption and stroke risk (p for non-linearity = 0.01). A level 
of consumption up to 200 ml per day was significantly asso-
ciated with lower risk of stroke compared with no consump-
tion, with lowest risk at 100%FJ consumption of 78 ml per 
day (RR = 0.78, 95% CI 0.66–0.92) (Fig. 1b). No heteroge-
neity was found (p = 0.44). By contrast, there was no signifi-
cant effect of higher levels of reported 100%FJ intake, above 
200 ml per day, compared with no 100%FJ consumption.
Separate analysis of the studies with unspecified fruit 
drink intake [11, 12] (overall, three cohorts, 118,771 par-
ticipants and 1039 events) again showed a non-linear asso-
ciation (p for non-linearity = 0.01). Fruit drinks intake was 
significantly and inversely associated with risk of stroke 
at moderate consumption (Online Resource-Supplemental 
Fig. 2). The analysis did not detect significant heterogeneity 
(p = 0.88).
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Fig. 1  Dose–response associa-
tion between 100% fruit juice 
consumption and cardiovas-
cular events. a Risk of total 
cardiovascular (CV) events. b 
Risk of stroke events. c Risk of 
coronary heart disease (CHD). 
100% fruit juice consumption 
was modelled with restricted 
cubic splines in a multivariate 
random-effects dose–response 
model (solid line). Dashed lines 
represent the 95% confidence 
intervals for the spline model
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Risk of coronary heart disease
The analysis of the two studies that investigated the asso-
ciation between 100%FJ intake and CHD [13, 14] (over-
all, 65,018 participants and 2273 events, Online Resource-
Supplemental Table 4) indicated no significant association 
between any consumption of 100%FJ and CHD risk (p for 
non-linearity = 0.15) (Fig. 1c). There was no heterogeneity 
between studies (p = 0.41). A further study evaluated CHD 
risk for 100%FJ intake, but there were no data available for 
dose–response analysis [17]. The main findings of this study 
indicated no significant increase in risk for a consumption of 
350 ml/day of 100%FJ consumption.
Separate dose–response analysis of the studies with 
unspecified fruit drink intake [16, 34] (overall, 3 cohorts, 
180,782 participants and 3265 events) showed no significant 
association between any consumption of fruit drinks and 
CHD risk (p for non-linearity = 0.86) (Online Resource-Sup-
plemental Fig. 3) and no evidence of heterogeneity among 
studies (p = 0.83). Other two studies not specifying the type 
of fruit drink consumed analysed the risk of CHD [12, 32], 
with data not available for dose–response analysis. In both 
studies, there was no association between fruit drink intake 
and CHD risk.
Risk of diabetes
The dose–response analysis of the five studies [35, 38, 42, 
44, 45] (overall, 286,083 participants and 17,894 new dia-
betes cases, Online Resource-Supplemental Table 5) that 
reported 100%FJ intake and risk of diabetes detected no 
significant association (p for non-linearity = 0.83) (Fig. 2), 
without heterogeneity among studies (p = 0.41). Separate 
analysis with available data on the relationship between 
citrus 100%FJ intake and diabetes risk [44, 45] showed 
similar results (p for non-linearity = 0.11; heterogeneity, 
p = 0.40) (Online Resource-Supplemental Fig. 3).
By contrast, additional analysis of the studies with 
unspecified fruit drink intake [36, 39–41, 43] (overall, 
five cohorts, 320,014 participants and 31,116 new diabetes 
cases, Online Resource-Supplemental Table 5) indicated 
a direct non-linear association between fruit drink con-
sumption and risk of diabetes (p for non-linearity < 0.001) 
(Online Resource-Supplemental Fig. 5). There was signifi-
cant heterogeneity among studies (p = 0.02).
RCTs A total of 35 RCTs were included in the different 
meta-analyses (Online Resource-Supplemental-Table 6). 
Only one study provided multiple groups including dif-
ferent categories of patients [61]. Six studies assessed 
the arterial stiffness by pulse wave velocity (PWV) and 
four the endothelial function using flow-mediated dila-
tion (FMD). The evaluation of the “risk of bias” indi-
cated that the majority of the studies were substantially at 
moderate-risk (Online Resource-Supplemental Table 3). 
Quality of body of evidence: the GRADE methodol-
ogy defines evidence from RCTs as high quality. This 
score was confirmed for the significant effect on BP and 
endothelial function and also for no effect on weight and 
lipids metabolism. For glucose metabolism, the quality 
was downgraded to moderate because of the large hetero-
geneity among studies.
The quality of the association between 100%FJ intake 
and arterial stiffness was downgraded from high to moderate 
level because of heterogeneity among studies. However, the 
quality level achieved the high GRADE score when the eval-
uation was performed on only carotid-femoral PWV results.
Fig. 2  Dose–response asso-
ciation between 100% fruit 
juice consumption and risk 
of diabetes. 100% fruit juice 
consumption was modelled 
with restricted cubic splines in 
a multivariate random-effects 
dose–response model (solid 
line). Dashed lines represent the 
95% confidence intervals for the 
spline model
2455European Journal of Nutrition (2021) 60:2449–2467 
1 3
Blood pressure
The meta-analysis of the effects of 100%FJ intake on bra-
chial BP included 25 studies [47–49, 52–54, 56, 58, 61–73, 
75, 76, 80, 81] (Online Resource-Supplemental Table 6). 
Pooled analyses showed a significant reduction of both sys-
tolic and diastolic BP upon 100%FJ intake in comparison 
with placebo or control drink (Fig. 3, Table 1). There was 
low heterogeneity for diastolic BP (Table 1). Visual anal-
ysis of the funnel plot indicated little asymmetry (Online 
Resource-Supplemental Figs. 6–7), whereas Egger’s and 
Begg’s tests did not find significant evidence of publication 
bias. Also, the “trim and fill” method did not identify any 
possibly missing study. Sensitivity analysis showed that the 
average change in BP did not vary substantially when any 
individual study or cohort was excluded.
Additional analyses Only the study design was a signifi-
cant source of heterogeneity for the effect on diastolic BP. Of 
note, sub-group analysis stratified by type of 100%FJ con-
sumed found that pomegranate juice significantly improved 
BP (Online Resource-Supplemental Table 8).
Body weight
Pooled analysis of the effect of 100%FJ intake on body 
weight changes showed no significant association for all 
the specific outcomes considered: weight, BMI, and waist 
circumference [46–48, 50, 52, 53, 57–65, 71, 72, 75–80] 
Fig. 3  100% fruit juice con-
sumption and blood pressure. a 
Forest plot of the effect of 100% 
fruit juice intake on systolic 
blood pressure (BP). b Forest 
plot of the effect of 100% fruit 
juice intake on diastolic blood 
pressure (BP). Results are 
expressed as Mean Difference 
(MD) and 95% confidence 
intervals (95% CI). Squares 
indicate study-specific rela-
tive risk estimates (size of the 
square reflects the study-specific 
statistical weight); horizontal 
lines indicate 95% CI; diamond 
indicates the overall relative risk 
with its 95% CI
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(Table 1, Online Resource-Supplemental Table 6, Fig. 4). 
For all the outcomes, there was no significant heteroge-
neity among studies and no evidence of publication bias 
(Table 1, Online Resource-Supplemental Figs. 8–10). 
Sensitivity analysis showed that the average change in 
different body weight expressions did not vary substan-
tially with the exclusion of any individual study or cohort.
Additional analyses No study characteristics affected 
the relationship between 100%FJ intake and body weight 
changes by meta-regression and subgroup analysis 
(Online Resource-Supplemental Table 9).
Lipid profile
The analyses of the effect of 100%FJ intake on the lipid 
metabolic profile did not detect any significant association 
for total cholesterol, LDL-cholesterol, HDL-cholesterol, 
and triglycerides [46–49, 51–62, 64, 66–68, 70–72, 75–77, 
80, 81] (Table 1, Online Resource-Supplemental Table 6, 
Online Resource-Supplemental Figs. 11–14). There was no 
significant heterogeneity among studies (Table 1), and no 
evidence of publication bias (Online Resource-Supplemental 
Figs. 15–18). The evaluation of single study effect did not 
Table 1  Meta-analysis of the association between 100% fruit juice intake and cardiovascular risk factors: results of randomised controlled trials
Outcome N of Stud-
ies (N of 
cohorts)






p-value Heterogeneity p, I2 Publication bias—





6 (6) 256 435 − 0.03 (−  0.41 to 
0.35)








25 (26) 1032 447 − 3.14 (-4.43 to 
− 1.85)
< 0.001 0.8, 0% 0.20; 0.40
 Diastolic blood 
pressure (mm Hg)
25 (26) 1032 447 − 1.68 (-2.94 to 
− 0.43)
< 0.001 0.06, 31% 0.12; 0.22
Body weight (46–48,50,52,53,57–65,71,72,75–80)
 Weight (kg) 19 (20) 805 464 − 0.07 (-0.39 to 
0.25)
0.67 1.0, 0% 0.53; 0.40
 BMI (kg/m2) 12 (13) 527 416 − 0.03 (− 0.15 to 
0.10)
0.67 1.0, 0% 0.66; 0.39
 Waist circumference 
(cm)




28 (29) 1,180 456 − 3.15 (− 6.43 to 
0.13)
0.06 0.99, 0% 0.35; 0.38
 LDL-cholesterol 
(mg/dl)
23 (23) 880 429 0.29 (− 2.62 to 3.20) 0.84 0.97, 0% 0.17; 0.10
 HDL-cholesterol 
(mg/dl)
25 (25) 1,007 414 0.43 (− 0.72 to 1.59) 0.85 0.34, 9% 0.10; 0.30
 Triglycerides (mg/
dl)
26 (26) 1,049 422 − 0.65 (− 5.83 to 
4.52)
0.80 1.0, 0% 0.77; 0.47
Glucose metabolism (47–54,57–59,62–64,67,68,70,74–81)
 Glucose (mg/dl) 23 (23) 845 409 − 1.01 (− 4.02 to 
2.00)
0.51 < 0.01, 69% 0.92; 0.85
 HOMA index (U) 11 (11) 487 415 0.01 (− 0.28 to 0.30) 0.50 0.66, 0% 0.80; 0.70
 Insulin (%) 11 (11) 424 430 3.4 (− 7.2 to 14.0) 0.53 0.88, 0% 0.80; 0.70
 Glycated haemoglo-
bin (%)
3 (3) 120 323 − 0.10 (− 0.31 to 
0.10)
0.32 0.98, 0% –
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Fig. 4  100% fruit juice con-
sumption and body weight. a 
Forest plot of the effect of 100% 
fruit juice intake on weight. 
b Forest plot of the effect of 
100% fruit juice intake on 
BMI. c Forest plot of the effect 
of 100% fruit juice intake on 
waist circumference. Results are 
expressed as Mean Difference 
(MD) and 95% confidence 
intervals (95% CI). Squares 
indicate study-specific rela-
tive risk estimates (size of the 
square reflects the study-specific 
statistical weight); horizontal 
lines indicate 95% CI; diamond 
indicates the overall relative risk 
with its 95% CI
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show significant associations for any of the included studies. 
However, only for total cholesterol, sensitivity analysis indi-
cated a significant inverse association between cholesterol 
changes and 100%FJ intake after exclusion of a few single 
studies.
Additional analyses Age and features of the participants, 
design of the studies, type of comparator used, characteris-
tics of 100%FJ, and diet during the studies were significant 
sources of heterogeneity on changes of HDL-cholesterol 
(Online Resource-Supplemental Table 10).
Glucose metabolism
Pooled analysis of the effect of 100%FJ intake on glucose 
metabolism showed no significant association for all the 
outcomes considered: serum glucose, HOMA index, serum 
insulin, and glycated haemoglobin [47–54, 57–59, 62–64, 
67, 68, 70, 74–81] (Table 1, Online Resource-Supplemen-
tal Table 6, Online Resource-Supplemental Figs. 19–22). 
Significant heterogeneity was observed only for serum 
glucose (Table 1). Visual analysis of the funnel plot indi-
cated little asymmetry only for changes in glucose levels 
(Online Resource-Supplemental Figs. 23–25), but the for-
mal tests did not find significant evidence of publication 
bias (Table 1). Sensitivity analysis showed that the average 
change in the different outcome levels did not vary substan-
tially with the exclusion of any individual study.
Additional analyses Meta-regression and subgroup 
analyses found gender, country of origin, characteristics of 
100%FJ and study design as significant sources of hetero-
geneity about the effect of 100%FJ intake on serum glucose 
(Online Resource-Supplemental Table 11). Analysis of the 
features that may affect changes in HOMA index detected 
only the type and the energy content of the comparator as 
significant sources of heterogeneity (Online Resource-Sup-
plemental Table 11).
Arterial stiffness
In the pooled analysis of six RCTs [53, 54, 65, 66, 75, 81] 
(Online Resource-Supplemental Table 6), 100%FJ intake 
was not associated with changes in PWV (Table 1, Online 
Resource-Supplemental Fig. 26). There was significant het-
erogeneity among studies (Table 1). Visual analysis of the 
funnel plot indicated little asymmetry (Online Resource-
Supplemental Fig. 27), whereas formal tests did not find 
significant evidence of publication bias (Table 1). Of note, 
changes in BP did not affect changes in PWV.
Separate analysis including only the studies using the 
carotid-femoral PWV changes (i.e., the gold standard for 
measuring large artery stiffness) [53, 54, 75, 81] (four stud-
ies, 162 total participants) indicated a significant beneficial 
effect of 100%FJ intake compared with the comparator drink 
(MD: − 0.38 m/s; p = 0.04). In addition, the analysis did 
not detect heterogeneity among studies (Online Resource-
Supplemental Fig. 26).
Flow‑mediated dilation
Pooled analysis of four RCTs [50, 54, 61, 75] (Online 
Resource-Supplemental Table 6) showed that 100%FJ intake 
was significantly associated with increased FMD compared 
with the comparator drink (Table 1, Online Resource-Sup-
plemental Fig. 28). There was no significant heterogeneity 
among studies and no evidence of publication bias (Table 1, 
Online Resource-Supplemental Fig. 29). Sensitivity analysis 
showed that the average change in FMD did not vary sub-
stantially when any individual cohort was excluded. Even 
in this case, changes in BP did not affect changes in FMD.
Discussion
Main study results
Our meta-analysis indicated that 100% FJ consumption is 
not associated with increased CV risk. Prospective data sup-
port a non-linear dose–response association between 100% 
FJ consumption and the rate of incident stroke and total CV 
disease, with evidence of a statistically significant beneficial 
effect at low-moderate intake (~ 80 ml/day). There was no 
significant association between 100% FJ consumption and 
risk of CHD or diabetes. The results of the RCTs support 
a beneficial effect on CV risk due to the favourable impact 
of 100% FJ intake on BP levels, arterial compliance and 
endothelial function. A neutral effect was detected on body 
weight, lipid profile and glucose metabolism. The results 
were supported by the GRADE categorization that detected 
high quality of the results for RCTs and moderate quality for 
prospective studies.
The results on CV risk were strengthened by no evi-
dence of heterogeneity among studies. While, in general, 
our results are consistent with the trend found by a previous 
systematic review [82], relevant elements of novel informa-
tion of the present meta-analysis include separate assess-
ment of the studies with specified 100% FJ intake, detailed 
dose–response analysis with detection in some cases of non-
linear relationships, and assessment of the quality of the 
results by GRADE categorization.
Our results are also substantially in agreement with 
a recent study of a European population [14, 83] show-
ing a non-linear relationship between 100%FJ consump-
tion and CV risk with significant benefit at low-moderate 
consumption.
By contrast, they are at variance with another recent study 
on a large American population, in which a very high 100% 
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FJ intake was associated with significantly higher CHD 
death rate [17]. The latter study had major limitations in 
the small number of CHD-related deaths, in the very large 
amount of 100% FJ intake considered for the assessment 
of risk, in the probable misclassification of 100%FJ intake 
and in the lack of assessment of a potential dose–response 
relationship.
100% FJ intake, BP and arterial function
The beneficial effect of moderate 100%FJ intake on CV risk, 
in particular on the risk of stroke, is supported by the results 
on BP. Pooled analysis of a large number of studies showed 
that 100% FJ intake was associated with a reduction of more 
than 3 mmHg for systolic and approximately 2 mmHg for 
diastolic BP. Compared with previous meta-analyses of the 
effects of 100%FJ intake on BP, our study used more strin-
gent inclusion criteria and adopted a robust methodology for 
the assessment of potential sources of heterogeneity, poten-
tial publication bias, robustness and quality of results. Fur-
thermore, we explored for the first time the effect of 100% 
FJ intake on arterial stiffness, an expression of CV organ 
damage [1]. In this regard, the analysis of the RCTs that 
used carotid-femoral PWV as a proxy for arterial stiffness 
did show a significant and favourable effect of 100% FJ. In 
line with this result are the findings on endothelial function: 
pooled analysis of FMD, another expression of early CV 
damage [84], found a significant improvement upon 100% 
FJ intake, with no significant heterogeneity among studies, 
no effect dependent on BP changes, and a high quality level 
as suggested by GRADE score.
Unfortunately, only two studies explored the risk to 
develop hypertension as a function of the consumption 
of fruit drinks [35, 37] (Online Resource-Supplemental 
Table 5). One American study, including young partici-
pants, suggested a significant and inverse trend between 
fruit drinks intake and risk of hypertension [37]. The other 
American study, including a large post-menopausal female 
sample, found a not significant association between 100% FJ 
consumption and development of hypertension at different 
levels of intake [35].
Possible mechanisms involved
Although our study has not the potential to shed light on 
pathophysiological mechanisms, it is conceivable that the 
relatively high amount of minerals, vitamins and bioactive 
compounds associated with 100% FJ consumption explain 
the benefit on CV risk [5, 85] and, in particular, on arterial 
stiffness, endothelial function, BP and risk of stroke.
In addition to the clinical and epidemiological evidence 
[85–87], many studies in animal models indicated that a 
high potassium intake may reduce CV organ damage, even 
independently from its effect on BP [88, 89]. A meta-anal-
ysis of RCTs suggested a beneficial effect of potassium 
intake on arterial stiffness [90].
Among the bioactive substances highly bioavailable 
in 100% FJ, polyphenols (e.g., hesperidin, naringenin) 
may contribute to the cardiovascular benefit, in particular 
by modulation of the nitric oxide (NO)–cGMP pathway. 
These compounds may regulate the levels and the activity 
of endothelial NO synthase and therefore NO bioavail-
ability [68, 91, 92], also involving intracellular  Ca2+ [93]. 
Polyphenols also cause inhibition of platelet aggregation, 
enhance release of platelet-derived NO, and reduce super-
oxide production [91, 94], oxidative DNA damage [55] 
and lipid peroxidation [95–97]. In addition, experimental 
studies suggested that hesperidin, the major polyphenol 
contained in orange juice, exerts its anti-inflammatory and 
antioxidant effects also by suppression of gene expression 
of some proinflammatory cytokines (e.g., TNF-a, IL-1β, 
IL-6) [98, 99], reduction of the expression of the intercel-
lular adhesion molecule-1 (ICAM-1) [100], and produc-
tion of metalloproteinases [94].
Also the antioxidant activity of vitamins may support 
the beneficial CV effect of 100% FJ intake. Vitamin A 
and derivatives were reported to reduce coronary heart 
disease risk [101] and this was attributed to modulation of 
endothelial cells differentiation and increase in NO synthe-
sis [102–104]. A high content of Vitamin C may contribute 
to endothelium-dependent vasodilation by increasing NO 
availability [105], in particular by modulation of endothe-
lial NO synthase [106]. Vitamin E decreases cell adhesion 
molecule expression [107] and monocyte adhesion to the 
endothelium [108]. Finally, folic acid content may exert 
beneficial effects on CV risk, by reducing homocysteine 
production and its detrimental effects [109, 110].
Based on the available evidence and on the results 
of our analyses, a biphasic dose–response relationships 
apparent, where the beneficial effect detected at low-
moderate 100% FJ consumption may be explained by the 
favourable health effect of “low dose” bioactive substances 
[111]. On the contrary, at a high level of consumption, the 
benefit may be offset by the unfavourable consequences of 
excess sugar and calorie intake [111].
Although there is an almost complete lack of studies 
comparing the effects on health outcomes of low-moderate 
consumption of 100%FJ with those of equivalent amounts 
of fresh fruit [76], it is indeed conceivable that the latter 
would be at least as beneficial as 100% FJ because of the 
higher content of fibre and in many cases of the other ben-
eficial compounds. Actually, the benefit associated with 
100% FJ intake in observational studies may result from 
partial compensation of a generally inadequate fresh fruit 
consumption at the population level.
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100% FJ intake, adiposity and risk of diabetes
100%FJ intake in our study appeared to have a neutral 
effect on adiposity in all its expressions. Noteworthy, none 
of the included RCTs show significant changes in body 
weight upon 100%FJ consumption. These results are in 
line with the recent prospective study by Garduño-Alanís 
et al. in 5000 Russian individuals indicating no significant 
BMI increase after 3 years of follow-up in 100%FJ con-
sumers [112]. Likewise, in a study on a large sample of 
post-menopausal women, 100%FJ consumption was asso-
ciated with only a small not clinically relevant increase in 
weigh after 3 years of follow-up [113]. A similar not clini-
cally relevant increase in BMI was also found in children 
and adolescents by a recent meta-analysis of prospective 
studies [114].
Other experimental investigations, in particular those on 
citrus 100%FJ, did not indicate a detrimental effect on body 
weight and actually suggested that citrus extracts may induce 
lipolysis [115, 116] and reduce fat accumulation [117], also 
by modulation of gut microbiota [118].
Our systematic review did not detect a significant associa-
tion between 100% FJ consumption and risk of diabetes and 
in this respect our results are in general consistent with those 
of previous meta-analyses [119, 120]. One of these indeed 
showed that the consumption of unspecified fruit drinks was 
associated with an increased risk of diabetes whereas that 
of 100% FJ was not [119]. In another recent meta-analysis 
by Imamura et al. [120] the consumption of sugary drinks 
and 100% FJ in excess of 250 ml per day was also associ-
ated with a significant increase in the risk of diabetes. Our 
dose–response analysis detected a non-linear significant 
direct association between fruit drinks consumption and 
risk of diabetes but no association for 100% FJ or citrus 
100%FJ intake. At variance with previously reported experi-
mental data [3, 4], our pooled analysis of RCTs indicated no 
significant association between 100% FJ intake and several 
parameters of glucose metabolism. In particular, 100% FJ 
intake did not affect serum levels of glucose and insulin nor 
the HOMA index. In addition, from the analysis of three 
available studies, there was no significant association with 
glycated-haemoglobin levels, further supporting a long-term 
neutral effect. These results confirm those found in previous 
meta-analyses [21, 22].
100% FJ intake and lipid profile
The exploration of the lipid profile showed no significant 
effect of 100% FJ intake in our meta-analysis. Previous sys-
tematic reviews as well as some experimental study reported 
a beneficial effect on lipid profile with consumption of 100% 
FJ [121–123].
Strengths and limitations
This study has several strengths: (a) the evaluation of 
both prospective and intervention studies; (b) the strin-
gent inclusion criteria; (c) a large number of participants 
for prospective evaluation and a large number of studies 
for intervention assessment; (d) the robustness of the find-
ings by sensitivity and sub-group analysis; (e) the com-
prehensive exploration of possible sources of heterogene-
ity; (f) the substantially low heterogeneity among studies 
and no evidence of publication bias; (g) the evaluation of 
shape and strength of the dose–response relationship; (h) 
the assessment of overall quality of evidence using the 
GRADE assessment approach.
On the other hand, the study also has limitations. For 
prospective studies, their observational nature impairs 
conclusions about possible cause-effect relationships.
Also the questionnaire to assess the extent of 100%FJ 
consumption is subject to limitations in prospective stud-
ies both in the administered and the self-administered ver-
sion, because of potential misclassification of quantity and 
quality of 100%FJ consumption.
The heterogeneity in the characteristics of the included 
studies is an important limitation, in particular for the RCTs, 
which varied for age, health status, type of 100%FJ utilized, 
serving size and comparator, length of intervention. This 
limitation was explored by sub-group and meta-regression 
analysis, which in general found little evidence of subgroup 
differences. However, in some subgroup analyses, the test 
was performed including relatively few studies in one of 
the subgroups, hence in those cases definitive conclusions 
cannot be reached. In the analysis of prospective studies, an 
important source of heterogeneity may be the different serv-
ing size due to geographical location, but this limitation was 
dealt with by dose–response analysis. Furthermore, although 
all the included prospective studies adjusted for several rel-
evant confounding factors (including age, body mass index, 
and other CV risk factors), residual confounding by other 
potential factors cannot be ruled out.
This meta-analysis was not able to detect consistent 
effects of individual types of 100% FJ, apart for the effect 
of pomegranate juice on BP, because of the low number 
of studies in each subgroup. Of note, a focused evalua-
tion of the citrus/orange 100% FJ effect, the most popular 
juice worldwide, suggests substantial similar results of 
this type of juice as compared to the unspecified 100%FJ 
both for CV outcomes [13, 14] and diabetes risk [35, 44, 
45]. There was also heterogeneity with regard to the fruit 
juices or fruit juice preparations used in the RCTs: nev-
ertheless, the effects observed in the studies that reported 
on reconstituted 100%FJ or fruit juices as such were not 
significantly different.
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Also, because few studies evaluated the effect of 100%FJ 
on CV organ damage, only the effect on arterial stiffness was 
explored by this meta-analysis. About CV organ damage, 
our systematic search detected only two studies that exam-
ined the effect of 100% FJ on other outcomes (i.e., carotid 
intima-media thickness) [124, 125]. One RCT, including 
approximately 300 participants at moderate CHD risk and 
with a relatively high intima-media thickness, found a not 
significant reduction in these values after 1 year of 240 ml 
of pomegranate juice supplementation [125]. The other one, 
non RCT, found progressively lower values in ten partici-
pants, during 1 year of 50 ml of pomegranate juice supple-
mentation [124].
Finally, further limitations are given by the relatively 
small number of prospective studies and cohorts available, 
by the residual possibility of publication bias and by the 
difficulty to draw definitive conclusions with regard to the 
interaction with age, gender and race given the peculiar 
composition of the study cohorts available. This notwith-
standing, the observational design and the process of meta-
analysis, with the calculation of a pooled estimate of the 
effect and the dose–response analysis in a large number of 
participants, are functional to overcome at least in part this 
problem.
Conclusions
The results of our study show that low-moderate 100% FJ 
consumption is not associated with increased risk of CV dis-
ease and that actually it is associated with apparent benefit 
against the development of CV events through a non-linear 
relationship. The positive changes in BP, arterial compliance 
and endothelial function may help explain the effect of 100% 
FJ intake on risk of CV disease, in particular on stroke risk. 
These findings are in keeping with the inverse association 
also occurring between regular fresh fruit consumption and 
risk of CV disease.
Given the importance of CV diseases [9, 10, 126, 127] 
and the popularity of fruit drinks consumption around the 
world [7, 8], the relationship between 100% FJ and CV risk 
assumes considerable relevance. Therefore, to clearly clas-
sify 100% FJ from unspecified fruit drink is crucial both 
for future research and for correct consumption. Further 
properly powered RCTs of the effect of long-term moder-
ate 100% FJ consumption are warranted to determine pos-
sible cause-effect relationships, to disentangle the effects 
of different types of 100% FJ (e.g., orange juice), and to 
overcome the currently limited evidence with respect to the 
interactions with age, ethnicity and diseases. In particular, 
intervention studies with carefully controlled intake of 100% 
FJ should evaluate the mechanisms of its effects on BP and 
CV organ damage to extend current knowledge in this field.
Implications for public health
Based on recent data, the overall average consumption of 
100% FJ is 38 ml per day [7], with women’s consumption 
being higher than that of men. Recent European estimates 
found an average consumption of 49 ml per day, with high-
est consumption in Western (52 ml) and lowest in Eastern 
countries (29 ml) [8].
International dietary guidelines are not in agreement 
on recommendations about 100%FJ consumption. In the 
United States, the Guidelines for Healthy Eating recom-
mend the daily consumption of two cups-equivalent of fruit 
(one cup = 237 ml), of which less than half can be taken as 
100% FJ [128]. For the American Heart Association, one 
of the recommended portions of fruit can be replaced by 
the consumption of 100%FJ (½ cup = 115 ml) [129]. In the 
United Kingdom, the dietary guidelines suggest that 100% 
FJ can contribute one portion of the daily fruit portion size 
(150 ml) [130]. Conversely, Dutch and Italian guidelines 
suggest more caution on 100% FJ consumption. Both guide-
lines do not recommend the consumption of 100%FJ in place 
of fresh fruit, because one classified 100%FJ in the category 
of sugar-containing beverages [131], and the Italian guide-
lines consider it as “unnecessary” consumption [132].
While fresh fruit in the proper amounts cannot be sur-
rogated by processed fruit consumption, the results of our 
study indicate no harm for the adult population from low-
moderate 100% FJ consumption and suggest that low-mod-
erate consumption of 100% FJ in the context of a balanced 
diet and as an alternative to sugar-sweetened beverages 
needs not to be discouraged. Although these results also 
show that high levels of 100% FJ intake were not associated 
with a detrimental CV effect, it would be hazardous to try 
to reach any conclusion on “safe levels” of intake, given the 
few prospective data available and the high heterogeneity 
of the level of consumption between trials and prospective 
studies. Therefore, only general consideration can be made. 
Indeed, it seems reasonable to suggest particular caution 
by overweight and obese individuals and by anyone else at 
higher risk of diabetes mellitus. Furthermore, more research 
is warranted to compare the effects on health outcomes of 
low-moderate consumption of 100% FJ with that of equiva-
lent amounts of fresh fruit, given the almost complete lack of 
sound information available in this respect [75, 133].
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